GlioQuell

Last updated: October 11, 2024

Kambiz Alavian, CEO
Kambiz Alavian, CEO
UK | Add Funding

Website: http://glioquell.com/

GlioQuell is a biopharmaceutical company dedicated to developing technologies and therapeutics targeting cellular bioenergetics. Based on cutting-edge proprietary science, the company is discovering and developing novel therapeutics for treating refractory brain tumours and other diseases with significant medical and societal burden.